Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion type Assertion NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_head.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion description "[To determine the relationship between the methylation status of the tumor suppressor and the tumor-related genes, and the clinicopathologic characteristics, including the survival rate, in patients with NSCLC after a surgical resection, we studied methylation in 10 genes (DAPK, FHIT, H-cadherin, MGMT, p14, p16, RAR-beta, RASSF1A, RUNX3, and TIMP-3) in 101 NSCLC cases by methylation-specific PCR (MSP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_provenance.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion evidence source_evidence_literature NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_provenance.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion SIO_000772 17606310 NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_provenance.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion wasDerivedFrom befree-2016 NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_provenance.
- NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_assertion wasGeneratedBy ECO_0000203 NP618097.RA4FrWi-q2rSzWrtjhLXt2BwphwUrDMUjkD0migBiJwYg130_provenance.